Kolexia
Pasquet Marlene
Pédiatrie
Hôpital Paule de Viguier
Toulouse, France
174 Activités
71 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémies Leucémie aigüe myéloïde Thrombopénie Purpura thrombopénique idiopathique Leucémie-lymphome lymphoblastique à précurseurs B et T Déficits immunitaires Neutropénie Purpura Anémie

Industries

Novartis
7 collaboration(s)
Dernière en 2022
Servier
5 collaboration(s)
Dernière en 2023
CSL Behring
2 collaboration(s)
Dernière en 2020
Gilead
2 collaboration(s)
Dernière en 2022

Dernières activités

A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia: ALLTogether1 - A Treatment Study Protocol of the ALLTogether Consortium for Children and Young Adults (0-45 Years of Age) With Newly Diagnosed Acute Lymphoblastic Leukaemia (ALL)
Essai Clinique (Mats Heyman)   18 mars 2024
Late-onset pulmonary complications following allogeneic hematopoietic cell transplantation in pediatric patients: a prospective multicenter study.
Bone marrow transplantation   07 mars 2024
Autoimmune cytopenia and Kabuki syndrome in paediatrics: Insights in 11 patients.
British journal of haematology   03 mars 2024
Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency.
Nature medicine   14 février 2024
Gene-ADA: ADA Gene Transfer Into Hematopoietic Stem/Progenitor Cells for the Treatment of ADA-SCID
Essai Clinique (Fondazione Telethon)   26 janvier 2024
Strimvelis Registry Study to Follow-up Patients With Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID): Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID) Registry for Patients Treated With Strimvelis (Previously GSK2696273) Gene Therapy: Long-Term Prospective, Non-Interventional Follow-up of Safety and Effectiveness
Essai Clinique (Fondazione Telethon)   26 janvier 2024
Antinuclear antibodies associated auto-immune cytopenia in childhood is a risk factor for systemic lupus erythematosus.
Blood   16 janvier 2024
IL-4Rα Inhibition for Severe "Eosinophilic Gastroenteritis, Allergy, and Anaphylaxis" Syndrome due to a Gain-of-Function Variant in STAT6.
Journal of clinical immunology   22 décembre 2023
GATA-2 Project: Retrospective and Prospective Exploratory Study for Characterisation of Predictive Parameters of Clonal Evolution in Subjects With GATA2 Germline Mutation
Essai Clinique (Institut Universitaire du Cancer Toulouse Oncopole)   11 décembre 2023
HOMOZYGOUS CBL MUTATION IN B LYMPHOCYTES AFTER CBL-DRIVEN JMML IMPAIRS B CELL MATURATION, FUNCTION AND ANTIBACTERIAL IMMUNITY
10th International Symposium of the European Working Group on Myelodysplastic Syndrome (EWOG-MDS) and Severe Aplastic Anemia (SAA) in Childhood   01 décembre 2023